MCRBのPER（株価収益率）は？

Seres Therapeutics Inc（MCRB）は現在PER 6.20倍で取引されています。

MCRBのROE（自己資本利益率）は？

Seres Therapeutics IncのROEは-176.98%です。

MCRBの配当利回りは？

Seres Therapeutics Incの配当利回りは0.00%です。

MCRBの品質スコア（Quality Score）は？

当社のAIはMCRBの総合財務品質を100点中23点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

MCRBは今が買い時ですか？

当社AIのタイミングスコアは100点中28点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

MCRBはどのセクターに属しますか？

Seres Therapeutics IncはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

MCRB (NASDAQ) 株価分析 | SERES THERAPEUTICS INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-05 | FS: 2026-03-31)

MCRB AI Analysis Summary

Our AI summary for MCRB: Seres Therapeutics Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 6.20, ROE of -176.98%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 28/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

MCRB

Seres Therapeutics Inc

US:NASDAQ STOCK Healthcare >> Biotechnology News 85

USD 5.01

-0.25 (-4.67%) Day Change

Watchlist Portfolio Compare Chart

6.20

P/E

0.41

D/E

-177.0%

ROE

-39.9%

ROA

0.00%

Div Yield

SERES THERAPEUTICS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 5.01 Price -0.25 (-4.67%) Day Change	NEWS SCORE: 85

MCRB, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROEが昨年度比で低い
ROAの伸びが低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Deepscope 分析

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	85
Magic Formula Rank by ROA	642
Magic Formula Rank by ROE	642
Magic Formula Rank by ROIC	918
Price	5.01
PBV / Sector	1.92 / 44,105.10
Earning Per Share	-4.62

PE / Sector	6.20 / 19.37 GREAT
PEG or PE/Growth / Sector	N/A / 1.06
Average 1M Daily Value	0.46 M GREAT
Average 1W Daily Value	0.31 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

43%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-4,088.84 / 97.23
NPM Average (%) / Sector	-1,741.61 / -1,697.84
NPM Change Average (%) / Sector	N/A / 5,097.59
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-39.87 / 185,260.64
ROA Average (%) / Sector	-48.80 / 36,684.64
ROA Change Average (%) / Sector	-249.14 / 422,221.42
ROE (%) / Sector	-176.98 / 243,761.81
ROE Average (%) / Sector	-658.77 / 48,758.38
ROE Change Average (%) / Sector	-551.37 / 424,967.86
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.42

登録情報

Analyze Date	2026-08-06 08:00:19
Symbol	MCRB
Name	SERES THERAPEUTICS INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	9.68 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	50.84 / 9,702.21

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 101 Cambridgepark Drive, Cambridge, MA, United States, 02140

Phone: 617 945 9626

Website: https://www.serestherapeutics.com

Employees: 66

Sector: Healthcare >> Biotechnology

Description: Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize GI pathogens, enhance GI epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation. It also develops SER-603, a LBP candidate optimized to treat disruptions in the GI microbiome and to improve GI mucosal barrier integrity through the inhibition of inflammatory bacteria and associated metabolites; and SER-147, a live biotherapeutic composition to prevent bacterial bloodstream and spontaneous bacterial peritonitis infections in patients with metabolic disease, including chronic liver disease. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.